Rare diseases
Investigational molecules
Locations
Back to Italy46 clinical trials in Misterbianco, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer treatments. Studies evaluate novel therapeutic combinations including targeted therapies and endocrine treatments.
Innovative approaches combining established treatments with new compounds to improve patient outcomes.
Research focusing on advanced pancreatic cancer and gastric cancer treatments, evaluating new combination therapies and maintenance strategies.
Studies aim to improve survival rates through innovative treatment combinations and maintenance strategies.
Clinical trials investigating treatments for Non-Small Cell Lung Cancer (NSCLC), including targeted therapies and immunotherapy combinations.
Focus on personalized treatment approaches based on specific genetic markers and disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
